Involvement of ERK-1/2 in IL-21-induced cytokine production in leukemia cells and human monocytes

Cytokine

Volumn 44, Issue 1, 2008, Pages 101-107

  Fuqua, C F ^a   Akomeah, R ^a   Price, J O ^b   Adunyah, S E ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Cytokines; ERK; IL 21; Leukemia; Monocytes

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; INTERLEUKIN 21; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONOCYTE; PRIORITY JOURNAL; UPREGULATION;

BUTADIENES; CYTOKINES; ENZYME ACTIVATION; HUMANS; INTERLEUKINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; NITRILES; SIGNAL TRANSDUCTION; U937 CELLS; UP-REGULATION;

EID: 52949149758     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.06.010     Document Type: Article

References (38)

1. Parrish-Novak J., Dillon J.R., Nelson A., Hammond A., Sprecher C., and Gross J.A. IL-21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000) 57-63
2. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201 (2005) 139-145
3. Di Carlo E., Comes A., Orengo A., Rosso O., Meazza R., Musiani P., et al. IL-21 induces tumor rejection by specific CTL and IFN-gamma dependent CXC chemokines in syngeneic mice. J Immunol 172 (2004) 1540-1547
4. Moroz A., Eppolito C., Li Q., Tao J., Clegg C.H., and Shrikant P.A. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparable evaluation of IL-2, IL-15, and IL-21. J Immunol 173 (2004) 900-909
5. Mehta D., Wurster A., Whitters M., Young D., Collins M., and Grusby M. IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 170 (2003) 4111-4118
6. Jin H., Carrio R., Yu A., and Malek T.R. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 173 (2004) 657-665
7. Asao H., Okuyama C., Kumaki S., Tsuchiya S., Foster D., and Sugamura K. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 167 (2001) 1-5
8. Sivakumar P., Foster D., and Clegg C. IL-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumor responses. Immunology 112 (2004) 177-182
9. Habib T., Nelson A., and Kaushansky K. IL-21: a novel IL-2 family lymphokine that modulates B, T, and NK cell responses. J Allergy Clin Immunol 112 (2004) 1033-1045
10. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher Z., et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298 (2002) 1630-1634
11. Ozaki K., Spolski R., Ettinger R., Kim H.P., Wang G., Qi C.F., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173 (2004) 5361-5371
12. Brady J., Hayakawa Y., Symth M J., and Nutt S.L. IL-21 induces the functional maturation of murine NK cells. J Immunol 172 (2004) 2048-2058
13. Wang G., Tschoi M., Sploski R., Lou Y., Ozaki K., Feng C., et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res 63 (2003) 9016-9022
14. Coquet J., Kyparissoudis K., Pellicci D., Besra G., Berzins S., Smyth M., et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol 178 (2007) 2827-2834
15. Wei L., Laurence A., Elias K.M., and O'Shea J.J. IL-21 is produced by TH17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 282 (2007) 34605-34610
16. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
17. ERK pathway inregulation of cytokine expression by Mycobacterium avium subsp paratuberculosis-exposed bovine monocytes. Am J Vet Res 68 (2007) 625-630
18. Stopak K., Chiu Y., Kropp J., Grant R., and Greene W.C. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem 282 (2007) 3539-3546
19. Alexander J.P., and Acott T.S. Involvement of the Erk-MAP kinase pathway in TNFα regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci 44 (2003) 164-169
20. De Totero D., Meazza R., Zupo S., Cutrona G., Matis S., Colombo M., et al. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood 107 (2006) 3708-3715
21. Malek T.R., and Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4 (2004) 665-674
22. Fehniger T.A., Cooper M.A., and Caligiuri M.A. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev 13 (2002) 169-183
23. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4 + CD25 naive T cells to CD4 + CD25 + regulatory T cells by TGFbeta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
24. Valzasina B., Piconese S., Guiducci C., and Colombo M.P. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25 lymphocytes is thymus and proliferation independent. Cancer Res 66 (2006) 4488-4495
25. Salazar-Onfray F., López M.N., and Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev 18 (2007) 171-182
26. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., et al. Cell biology of IL-7 a key lymphotrophin. Cytokine Growth Factor Rev 16 (2005) 513-533
27. Platanias L.C., and Fish E.N. Signaling pathways activated by interferons. Exp Hematol 27 (1999) 1583-1592
28. Inoue Y., Tsushima H., Ando K., Sawayama Y., Sakai M., Yamasaki R., et al. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines. Exp Hematol 34 (2006) 19-26
29. Neville L.F., Mathiak G., and Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 8 (1997) 207-219
30. Dinarello C.A. Interleukin-1. Cytokine Growth Factor Rev 8 (1997) 253-265
31. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12 (2001) 375-391
32. Menten P., Wuyts A., and Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13 (2002) 455-481
33. Makishima H., Ito T., Momose K., Nakazawa H., Shimodaira S., Kamijo Y., et al. Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Leuk Res 9 (2007) 1237-1245
34. Van Coillie E., Van Damme J., and Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 10 (1999) 61-86
35. Okuma E., Inazawa Y., Saeki K., and You A. Potential role of extracellular signal-regulated kinase but not p38 during myeloid differentiation of U937 cells stimulated by cytokines: augmentation of differentiation via prolonged activation of extracellular signal-regulated kinase. Exp Hematol 30 (2002) 571-581
36. Sachs L. The cellular and molecular environment in leukemia. Blood Cells 19 (1993) 709-730
37. Furukawa J., Hara I., Nagai H., Yao A., Oniki S., and Fujisawa M. Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response. J Urol 17 (2006) 1198-1203
38. Curti B.D. Immunomodulatory and antitumor effects of IL-21 in patients with renal cell carcinoma. Expert Rev Anticancer Ther 6 (2006) 905-909